Zortrax S.A.

Equities

ZRX

PLCRLNS00018

Medical Equipment, Supplies & Distribution

End-of-day quote Warsaw S.E. Other stock markets 06:00:00 2024-06-26 pm EDT			5-day change	1st Jan Change
0.132 ^PLN	-0.75%		-1.49%	-57.28%

May. 15	Zortrax S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Feb. 14	Zortrax S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI

Zortrax S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024

May 14, 2024

Zortrax S.A. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported revenue was PLN 2.47 million compared to PLN 4.63 million a year ago. Net loss was PLN 4.1 million compared to PLN 3.72 million a year ago.

Latest news about Zortrax S.A.

Zortrax S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 14	CI
Zortrax S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 14	CI
Zortrax S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13	CI
Zortrax S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
Zortrax S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	23-02-14	CI
Zortrax S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-11	CI
Rusatcom Additive Technlogies LLC cancelled the acqusition of an unknown stake in Zortrax SA from Marcin Olchanowski, Rafal Tomasiak and Mariusz Babula.	22-02-28	CI
Rusatcom Additive Technlogies LLC entered into a term sheet to acquire an unknown stake in Zortrax SA from Marcin Olchanowski, Rafal Tomasiak and Mariusz Babula.	21-07-18	CI
Zortrax SA completed the acquisition of Corelens S.A. in a reverse merger transaction.	21-06-13	CI
Corelens S.A. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-14	CI
Corelens S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2020	21-02-12	CI
Zortrax SA signed a letter of intent to acquire Corelens S.A. in a reverse merger transaction for approximately PLN 310 million.	20-09-07	CI
Zortrax Mulls Listing In 2016	15-11-19	CI
Zortrax Seeks IPO	15-02-09	CI
Zortrax Mulls IPO	14-03-11	CI

Chart Zortrax S.A.

Duration

Period

More charts

Company Profile

Zortrax SA, formerly Corelens SA, is a Poland-based company providing specialized solutions for the ophthalmic industry. The Company's business clients are public and private medical centers in Poland and the main product are intraocular lenses, which are used by doctors in cataract surgery. Other Company's products include surgical sets and disposable tools, viscoelastics and diagnostic equipment, also used by ophthalmologists during cataract surgery.

Sector

Medical Equipment, Supplies & Distribution

More about the company

Income Statement Evolution

More financial data

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
ZORTRAX S.A.	-57.28%	3.8M
ABBOTT LABORATORIES	-4.92%	182B
MEDTRONIC PLC	-3.70%	103B
BECTON, DICKINSON AND COMPANY	-5.29%	66.94B
CENCORA, INC.	+10.99%	46.73B
DEXCOM, INC.	-7.70%	45.14B
HOYA CORPORATION	+6.10%	41.57B
METTLER-TOLEDO INTERNATIONAL, INC.	+15.96%	30.48B
TERUMO CORPORATION	+12.55%	24.26B
WEST PHARMACEUTICAL SERVICES, INC.	-6.63%	23.58B

Other Medical Equipment, Supplies & Distribution